v3 Template
B

BioMarin Pharmaceutical Inc.

Biotechnology San Rafael, California ~420 employees
Founded
--
Employees (Est.)
~420
21 leaders known
Total Funding
$2.5B
Funding Rounds
3
Last Funding
2026-02-12

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. is a global biotechnology company founded in 1997, focused on translating genetic discoveries into transformative medicines for life-threatening conditions. They have eight marketed products and an industry-leading pipeline of investigational medicines for rare genetic and lysosomal storage diseases, achondroplasia, and severe hemophilia A.

Products & Services

Marketed Products:Eight approved medicines for treating life-threatening conditions such as achondroplasia, severe hemophilia A, and rare inherited and lysosomal storage diseases.
Pipeline:An industry-leading pipeline of investigational medicines in various stages of clinical and preclinical development.
Voxzogo (vosoritide)

Specialties

Genetic Conditions Rare Diseases Lysosomal Storage Diseases Achondroplasia Severe Hemophilia A Bioanalytical Sciences Rare genetic diseases Metabolic disorders Hypochondroplasia ENPP1 deficiency

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt
A: 850000000
MR: -
FA: 850 million
FAN: 850000000
D: 2026-02-12
FD: 2026-02-12
-
2 RT: Private offering of senior unsecured notes and senior secured term loan facilities
T: -
FT: Private offering of senior unsecured notes and senior secured term loan facilities
A: 850000000
MR: -
FA: $850 million
FAN: 850000000
D: 2026-01-29
FD: 2026-01-29
-
3 RT: Debt
T: -
FT: Debt
A: 850000000
MR: -
FA: $850 million
FAN: 850000000
D: 2026-01-26
FD: 2026-01-26
-
Debt Latest
2026-02-12
$850.0M
Private offering of senior unsecured notes and senior secured term loan facilities 2026-01-29
$850.0M
Debt 2026-01-26
$850.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

A

Alexander Hardy

President and Chief Executive Officer

A

Arpit Davé

Executive Vice President, Chief Digital and Information Officer

G

G. Eric Davis

Executive Vice President, Chief Legal Officer

G

Greg Friberg

Executive Vice President, Chief Research & Development Officer

C

C. Greg Guyer

Executive Vice President, Chief Technical Officer

C

Cristin Hubbard

Executive Vice President, Chief Commercial Officer

View 18 more team members with Pro

Unlock Full Team Directory

Recent News

BioMarin Pharmaceutical Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~420 employees (est.)
Locations
San Rafael, California

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro